UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

The New England journal of medicine, 2018-08, Vol.379 (8), p.753-763

2018

Volltextzugriff (PDF)

Design of roll profile for LM-Guide block in Horizontal-Vertical shape rolling by 3D-EFA

International journal of precision engineering and manufacturing, 2015-04, Vol.16 (4), p.767-773

2015

Volltextzugriff (PDF)

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index

PloS one, 2015-10, Vol.10 (10), p.e0139749-e0139749

2015

Volltextzugriff (PDF)

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

The lancet oncology, 2020-06, Vol.21 (6), p.808-820

2020

Volltextzugriff (PDF)

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

JNCI : Journal of the National Cancer Institute, 2019-12, Vol.111 (12), p.1298-1306

2019

Volltextzugriff (PDF)

The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology

BMC medicine, 2022-02, Vol.20 (1), p.72-72, Article 72

2022

Volltextzugriff (PDF)

IFI16/Ifi202 released from breast cancer induces secretion of inflammatory cytokines from macrophages and promotes tumor growth

Journal of cellular physiology, 2023-07, Vol.238 (7), p.1507-1519

2023

Volltextzugriff (PDF)

Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma – Authors' replys

The lancet oncology, 2020-09, Vol.21 (9), p.e413-e413

2020

Volltextzugriff (PDF)

Circulating Osteocalcin‐Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients

Journal of bone and mineral research, 2020-10, Vol.35 (10), p.1838-1849

2020

Volltextzugriff (PDF)

HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results

Breast cancer research : BCR, 2023-12, Vol.25 (1), p.154-154, Article 154

2023

Volltextzugriff (PDF)

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

The oncologist (Dayton, Ohio), 2020-03, Vol.25 (3), p.e439-e450

2020

Volltextzugriff (PDF)

Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

Nature communications, 2021-08, Vol.12 (1), p.4840-14, Article 4840

2021

Volltextzugriff (PDF)

A phase II trial of the pan‐HER inhibitor poziotinib, in patients with HER2‐positive metastatic breast cancer who had received at least two prior HER2‐directed regimens: results of the NOV120101‐203 trial

International journal of cancer, 2018-12, Vol.143 (12), p.3240-3247

2018

Volltextzugriff (PDF)

Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression

Breast cancer research and treatment, 2019-10, Vol.177 (3), p.549-559

2019

Volltextzugriff (PDF)

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study

Cancer science, 2020-02, Vol.111 (2), p.513-527

2020

Volltextzugriff (PDF)

HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis

BMC medicine, 2022-03, Vol.20 (1), p.105-15, Article 105

2022

Volltextzugriff (PDF)

Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer

Scientific reports, 2020-06, Vol.10 (1), p.9930, Article 9930

2020

Volltextzugriff (PDF)

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000453

2020

Volltextzugriff (PDF)

AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells

Molecular cancer therapeutics, 2017-04, Vol.16 (4), p.566-577

2017

Volltextzugriff (PDF)

Molecular alterations and poziotinib efficacy, a pan‐HER inhibitor, in human epidermal growth factor receptor 2 (HER2)‐positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2‐positive breast cancer patients

International journal of cancer, 2019-09, Vol.145 (6), p.1669-1678

2019

Volltextzugriff (PDF)

An Antibody‐CRISPR/Cas Conjugate Platform for Target‐Specific Delivery and Gene Editing in Cancer

Advanced science, 2024-06, Vol.11 (21), p.e2308763-n/a

2024

Volltextzugriff (PDF)

Performance and characteristics of titanium nitride, chromium nitride, multi-coated stainless steel 304 bipolar plates fabricated through a rubber forming process

International journal of hydrogen energy, 2015-06, Vol.40 (20), p.6681-6688

2015

Volltextzugriff (PDF)

Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells

Cancer letters, 2018-08, Vol.430, p.123-132

2018

Volltextzugriff (PDF)

Mutational evolution after chemotherapy‐progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis

International journal of cancer, 2023-08, Vol.153 (3), p.571-583

2023

Volltextzugriff (PDF)

Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial

Breast cancer research and treatment, 2020-07, Vol.182 (1), p.97-105

2020

Volltextzugriff (PDF)

1 – 25 von 5.854

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.749)
Mit Volltextzugriff
(4.578)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(4.893)
Koreanisch
(950)
Japanisch
(18)
Chinesisch
(5)
Deutsch
(2)
Spanisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.075)
Life Sciences & Biomedicine
(2.226)
Humans
(1.348)
Female
(923)
Male
(823)
Middle Aged
(696)
Physical Sciences
(599)
Technology
(571)
Aged
(556)
Adult
(546)
Animals
(431)
Chemistry
(362)
Oncology
(356)
Original
(328)
Biological And Medical Sciences
(305)
Materials Science
(293)
Science & Technology - Other Topics
(269)
Medical Sciences
(256)
Treatment Outcome
(250)
Engineering
(246)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

Design of roll profile for LM-Guide block in Horizontal-Vertical shape rolling by 3D-EFA

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology

IFI16/Ifi202 released from breast cancer induces secretion of inflammatory cytokines from macrophages and promotes tumor growth

Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma – Authors' replys

Circulating Osteocalcin‐Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients

HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

A phase II trial of the pan‐HER inhibitor poziotinib, in patients with HER2‐positive metastatic breast cancer who had received at least two prior HER2‐directed regimens: results of the NOV120101‐203 trial

Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study

HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis

Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors

AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells

Molecular alterations and poziotinib efficacy, a pan‐HER inhibitor, in human epidermal growth factor receptor 2 (HER2)‐positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2‐positive breast cancer patients

An Antibody‐CRISPR/Cas Conjugate Platform for Target‐Specific Delivery and Gene Editing in Cancer

Performance and characteristics of titanium nitride, chromium nitride, multi-coated stainless steel 304 bipolar plates fabricated through a rubber forming process

Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells

Mutational evolution after chemotherapy‐progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis

Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial

Suchergebnisse filtern